What Happened?
San Mateo, AB-based Terns Pharmaceuticals Appointed Weidong Zhong as Founder and Chief Executive Officer
About the Company
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
About the Person
Weidong Zhong is Founder and Chief Executive Officer at Terns Pharmaceuticals. Previously, Weidong held various senior HR leadership roles in the industry.
Info Source
News
Short Profile